tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Stephanie Davis, 132 are a BUY (58.67%), 76 are a HOLD (33.78%), 17 are a SELL (7.56%).
Analyst Stephanie Davis, carries an average stock price target met ratio of 76.71% that have a potential upside of 19.5% achieved within 171 days. Previously, Stephanie Davis worked at LEERINK.
Stephanie Davis’s has documented 423 price targets and ratings displayed on 32 stocks. The coverage was on Healthcare, Technology sectors.
Most recent stock forecast was given on DGX, Quest Diagnostics at 31-Jan-2025.
Analyst best performing recommendations are on LVGO (LIVONGO HEALTH).
The best stock recommendation documented was for PHR (PHREESIA) at 3/31/2022. The price target of $29 was fulfilled within 1 day with a profit of $2.64 (10.02%) receiving and performance score of 100.15.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$5.75
3 months 19 days ago
(08-Jan-2025)
4/12 (33.33%)
$1.71 (42.33%)
54
Hold
$7.03
$0.01 (0.14%)
$8
3 months 19 days ago
(08-Jan-2025)
4/10 (40%)
$0.17 (2.48%)
139
Hold
$16
3 months 19 days ago
(08-Jan-2025)
2/3 (66.67%)
$1.01 (6.74%)
79
$5
$-2.02 (-28.77%)
$6
4 months 10 days ago
(17-Dec-2024)
10/13 (76.92%)
$1.6 (47.06%)
44
Hold
$6
$-1.02 (-14.53%)
$7
6 months 16 days ago
(11-Oct-2024)
10/11 (90.91%)
$2.21 (58.31%)
70
Which stock is Stephanie Davis is most bullish on?
Which stock is Stephanie Davis is most reserved on?
What Year was the first public recommendation made by Stephanie Davis?
